Key result
Review details the mechanisms by which diverse pharmacological agents modify intracellular calcium release channels.
Why the study?
Intracellular Ca(2+) release channels have important pathophysiological roles in cardiac arrhythmias and heart failure, motivating the identification of novel selective pharmacological regulators.
Answers are grounded in this paper and cite their sources.
This review provides a comprehensive overview of pharmacological regulators of intracellular calcium release channels, highlighting their potential relevance in treating cardiac arrhythmias and heart failure.
Intracellular Ca(2+) release channels, such as inositol 1,4,5-trisphosphate receptors (IP(3)Rs) and ryanodine receptors (RyRs), facilitate the release of Ca(2+) from intracellular storage organelles in response to extracellular and intracellular stimuli. Consequently, these large, tetrameric proteins play a central role in Ca(2+) signalling and Ca(2+) homeostasis in virtually all cells. Recent data suggests that intracellular Ca(2+) release channels may also have an important pathophysiological function in certain disease states, including cardiac arrhythmias and heart failure. As a result, there has been much interest in the identification and characterization of novel, selective regulators of these channels. In this article, we review the wide array of pharmacological agents that interact directly with intracellular Ca(2+) release channels and describe the mechanisms underlying their ability to modify channel function.
No takes yet. Share an insight, caveat, or question.
West et al. (2007) reported a review. Pharmacological regulators of intracellular calcium release channels was evaluated. This review describes the wide array of pharmacological agents that interact directly with intracellular calcium release channels and their mechanisms of modifying channel function.
Synapse has enriched 10 related papers. Consider them for comparative context: